A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 396 participants.
Also called NCT02749994
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 396 participants
- Sponsor
- Registry
-
NCT02749994
-
- Other papers using this trial's data
- A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02749994. Randomized; double masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2017-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)
- Acronym
- I-ROSETTE
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Rosuvastatin
- Intervention (Drug)
- Ezetimibe
- Lead sponsor
- IlDong Pharmaceutical Co Ltd
Record details
- Record id
cardio:ct-nct02749994- Content hash
70a41371053ed5eb4fe987acd128f9fdee186480065aef5a6ccb1a1ef36842e9